205 related articles for article (PubMed ID: 18417150)
1. Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
Abe Y; Yoshikawa T; Kamada H; Shibata H; Nomura T; Minowa K; Kayamuro H; Katayama K; Miyoshi H; Mukai Y; Yoshioka Y; Nakagawa S; Tsunoda S; Tsutsumi Y
J Immunol Methods; 2008 Jun; 335(1-2):71-8. PubMed ID: 18417150
[TBL] [Abstract][Full Text] [Related]
2. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.
Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081
[TBL] [Abstract][Full Text] [Related]
3. Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2.
Shibata H; Abe Y; Yoshioka Y; Nomura T; Sato M; Kayamuro H; Kawara T; Arita S; Furuya T; Nagano K; Yoshikawa T; Kamada H; Tsunoda S; Tsutsumi Y
Cytokine; 2010 Apr; 50(1):75-83. PubMed ID: 20045350
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitors.
Depuydt B; van Loo G; Vandenabeele P; Declercq W
J Cell Sci; 2005 Feb; 118(Pt 3):497-504. PubMed ID: 15657078
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching.
Rae C; MacEwan DJ
Cell Death Differ; 2004 Dec; 11 Suppl 2():S162-71. PubMed ID: 15459750
[TBL] [Abstract][Full Text] [Related]
7. Generation of a sensitive TNFR2-specific murine assays system.
Ando D; Kamada H; Inoue M; Taki S; Furuya T; Abe Y; Nagano K; Tsutsumi Y; Tsunoda S
Pharmazie; 2016 May; 71(5):235-7. PubMed ID: 27348964
[TBL] [Abstract][Full Text] [Related]
8. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
[TBL] [Abstract][Full Text] [Related]
9. Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2.
Boschert V; Krippner-Heidenreich A; Branschädel M; Tepperink J; Aird A; Scheurich P
Cell Signal; 2010 Jul; 22(7):1088-96. PubMed ID: 20206684
[TBL] [Abstract][Full Text] [Related]
10. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
[TBL] [Abstract][Full Text] [Related]
11. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.
Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR
Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074
[TBL] [Abstract][Full Text] [Related]
12. TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor.
Wüest T; Gerlach E; Banerjee D; Gerspach J; Moosmayer D; Pfizenmaier K
Oncogene; 2002 Jun; 21(27):4257-65. PubMed ID: 12082613
[TBL] [Abstract][Full Text] [Related]
13. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis.
Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C
Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899
[TBL] [Abstract][Full Text] [Related]
14. The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection.
Kafrouni MI; Brown GR; Thiele DL
J Leukoc Biol; 2003 Oct; 74(4):564-71. PubMed ID: 12960267
[TBL] [Abstract][Full Text] [Related]
15. Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.
Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Minowa K; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Feb; 65(2):93-6. PubMed ID: 20225650
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
Barnes JL; Williams NL; Ketheesan N
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
[TBL] [Abstract][Full Text] [Related]
18. Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways.
Veroni C; Gabriele L; Canini I; Castiello L; Coccia E; Remoli ME; Columba-Cabezas S; Aricò E; Aloisi F; Agresti C
Mol Cell Neurosci; 2010 Nov; 45(3):234-44. PubMed ID: 20600925
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
[TBL] [Abstract][Full Text] [Related]
20. Infliximab and the TNF-alpha system.
Ebert EC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G612-20. PubMed ID: 19136378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
